It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Pfizer, the world's third largest drug maker, has announced it is ending research to discover new medications for Alzheimer's and Parkinson's disease.
The move, which will eliminate hundreds of research positions across the pharmaceutical giant's roster, casts an even darker shadow outside the company – dashing the hopes of millions affected by neurological disorders, whose dreams of finding a treatment just got that much more desperate.
The pharmaceutical giant explained its decision, which will entail roughly 300 layoffs, as a move to better position itself "to bring new therapies to patients who need them."
"As a result of a recent comprehensive review, we have made the decision to end our neuroscience discovery and early development efforts and re-allocate [spending] to those areas where we have strong scientific leadership and that will allow us to provide the greatest impact for patients," Pfizer said in a statement emailed to NPR.
Pfizer added that it will "continue to fully support" development on tanezumab and Lyrica, two treatments targeting chronic pain, as well as programs researching rare neurological diseases.
The round of several hundred layoffs "will take place over the coming months" at its research and development labs in the Northeast — specifically, sites in Cambridge and Andover, Mass., and in Groton, Conn.
"Any decision impacting colleagues is difficult; however, we believe this will best position the company to bring meaningful new therapies to market, and will bring the most value for shareholders and patients."
originally posted by: Skywatcher2011
One of World's Biggest Drug Companies Just Abandoned Alzheimer's And Parkinson's Research
www.sciencealert.com...
Pfizer, the world's third largest drug maker, has announced it is ending research to discover new medications for Alzheimer's and Parkinson's disease.
The move, which will eliminate hundreds of research positions across the pharmaceutical giant's roster, casts an even darker shadow outside the company – dashing the hopes of millions affected by neurological disorders, whose dreams of finding a treatment just got that much more desperate.
The pharmaceutical giant explained its decision, which will entail roughly 300 layoffs, as a move to better position itself "to bring new therapies to patients who need them."
"As a result of a recent comprehensive review, we have made the decision to end our neuroscience discovery and early development efforts and re-allocate [spending] to those areas where we have strong scientific leadership and that will allow us to provide the greatest impact for patients," Pfizer said in a statement emailed to NPR.
Pfizer added that it will "continue to fully support" development on tanezumab and Lyrica, two treatments targeting chronic pain, as well as programs researching rare neurological diseases.
The round of several hundred layoffs "will take place over the coming months" at its research and development labs in the Northeast — specifically, sites in Cambridge and Andover, Mass., and in Groton, Conn.
"Any decision impacting colleagues is difficult; however, we believe this will best position the company to bring meaningful new therapies to market, and will bring the most value for shareholders and patients."
This is a total business/profits move and nothing more. So another round of Big Pharma pulling all the strings into making money.
I wonder if this wasn't just a profit move, but maybe some secret cure that was discovered which completely reversed Alz and Park's diseases and so Pfizer quickly shut down the lab which discovered the findings. There are always 2 sides to every story.
originally posted by: Bluntone22
a reply to: Skywatcher2011
Maybe they realized they spent a lot of money and got very little return on their investment.
originally posted by: JAGStorm
a reply to: Skywatcher2011
The Pharma industry always defends their high prices because of all of the costs of research and development and to keep the pipeline going. This is just sick, now they are showing their true colors, they never cared, and all it has ever been about is the $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
originally posted by: Bluntone22
a reply to: Skywatcher2011
Maybe they realized they spent a lot of money and got very little return on their investment.
originally posted by: JAGStorm
a reply to: Skywatcher2011
The Pharma industry always defends their high prices because of all of the costs of research and development and to keep the pipeline going. This is just sick, now they are showing their true colors, they never cared, and all it has ever been about is the $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
originally posted by: Bluntone22
originally posted by: JAGStorm
a reply to: Skywatcher2011
The Pharma industry always defends their high prices because of all of the costs of research and development and to keep the pipeline going. This is just sick, now they are showing their true colors, they never cared, and all it has ever been about is the $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
You know what you call a company that doesn't make a profit?
Closed....
originally posted by: seasonal
a reply to: Skywatcher2011
They must have found out that sugar is the main cause for these types of maladies (maybe).
Alzheimer's Disease Is Type 3 Diabetes–Evidence Reviewed
www.ncbi.nlm.nih.gov...
originally posted by: JAGStorm
a reply to: seasonal
I have my theories, but sugar isn't one of them (but I do think it is a main issue in cancer).
aluminum, exposure to chemicals something along those lines.
originally posted by: JAGStorm
a reply to: NobodyToldMe
super interesting stuff, not a lot of research has been done on CTE yet but the symptoms sound oddly familiar
Memory loss
Confusion
Personality changes (including depression and suicidal thoughts)
Erratic behavior (including aggression)
Problems paying attention and organizing thoughts
Difficulty with balance and motor skills
On a side note, it is interesting to see that research is being done to connect the link of brain injury and crime/violence.